Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

Skin deep: what can the study of dermal fibroblasts teach us about dilated cardiomyopathy?

Jensen BC.

J Mol Cell Cardiol. 2010 Apr;48(4):576-8. doi: 10.1016/j.yjmcc.2009.11.021. Epub 2009 Dec 11. No abstract available.

2.
3.

Cardiac-myocyte-specific excision of the vinculin gene disrupts cellular junctions, causing sudden death or dilated cardiomyopathy.

Zemljic-Harpf AE, Miller JC, Henderson SA, Wright AT, Manso AM, Elsherif L, Dalton ND, Thor AK, Perkins GA, McCulloch AD, Ross RS.

Mol Cell Biol. 2007 Nov;27(21):7522-37. Epub 2007 Sep 4.

4.

A NADH dehydrogenase ubiquinone flavoprotein is decreased in patients with dilated cardiomyopathy.

Ono H, Nakamura H, Matsuzaki M.

Intern Med. 2010;49(19):2039-42. Epub 2010 Oct 1.

5.

Absence of thrombospondin-2 causes age-related dilated cardiomyopathy.

Swinnen M, Vanhoutte D, Van Almen GC, Hamdani N, Schellings MW, D'hooge J, Van der Velden J, Weaver MS, Sage EH, Bornstein P, Verheyen FK, VandenDriessche T, Chuah MK, Westermann D, Paulus WJ, Van de Werf F, Schroen B, Carmeliet P, Pinto YM, Heymans S.

Circulation. 2009 Oct 20;120(16):1585-97. doi: 10.1161/CIRCULATIONAHA.109.863266. Epub 2009 Oct 5.

6.

Gene expression profile in dilated cardiomyopathy caused by elevated frequencies of mitochondrial DNA mutations in the mouse heart.

Zhang D, Ezekiel UR, Chang SW, Zassenhaus HP.

Cardiovasc Pathol. 2005 Mar-Apr;14(2):61-9.

PMID:
15780797
7.

Injection of vessel-derived stem cells prevents dilated cardiomyopathy and promotes angiogenesis and endogenous cardiac stem cell proliferation in mdx/utrn-/- but not aged mdx mouse models for duchenne muscular dystrophy.

Chun JL, O'Brien R, Song MH, Wondrasch BF, Berry SE.

Stem Cells Transl Med. 2013 Jan;2(1):68-80. doi: 10.5966/sctm.2012-0107. Epub 2012 Dec 27. Erratum in: Stem Cells Transl Med. 2013 Feb;2(2):following 158.

8.

Synthetic prostacyclin agonist, ONO1301, enhances endogenous myocardial repair in a hamster model of dilated cardiomyopathy: a promising regenerative therapy for the failing heart.

Ishimaru K, Miyagawa S, Fukushima S, Saito A, Sakai Y, Ueno T, Sawa Y.

J Thorac Cardiovasc Surg. 2013 Dec;146(6):1516-25. doi: 10.1016/j.jtcvs.2013.02.045.

9.

Modeling of lamin A/C mutation premature cardiac aging using patient‐specific induced pluripotent stem cells.

Siu CW, Lee YK, Ho JC, Lai WH, Chan YC, Ng KM, Wong LY, Au KW, Lau YM, Zhang J, Lay KW, Colman A, Tse HF.

Aging (Albany NY). 2012 Nov;4(11):803-822.

10.

Disruption of cardiac Ena-VASP protein localization in intercalated disks causes dilated cardiomyopathy.

Eigenthaler M, Engelhardt S, Schinke B, Kobsar A, Schmitteckert E, Gambaryan S, Engelhardt CM, Krenn V, Eliava M, Jarchau T, Lohse MJ, Walter U, Hein L.

Am J Physiol Heart Circ Physiol. 2003 Dec;285(6):H2471-81. Epub 2003 Aug 21.

11.

Cardiac dysfunction and pathology in the dystrophin and utrophin-deficient mouse during development of dilated cardiomyopathy.

Chun JL, O'Brien R, Berry SE.

Neuromuscul Disord. 2012 Apr;22(4):368-79. doi: 10.1016/j.nmd.2011.07.003. Epub 2012 Jan 21.

PMID:
22266080
12.

Loss of αT-catenin alters the hybrid adhering junctions in the heart and leads to dilated cardiomyopathy and ventricular arrhythmia following acute ischemia.

Li J, Goossens S, van Hengel J, Gao E, Cheng L, Tyberghein K, Shang X, De Rycke R, van Roy F, Radice GL.

J Cell Sci. 2012 Feb 15;125(Pt 4):1058-67. doi: 10.1242/jcs.098640. Epub 2012 Mar 15.

13.

LMNA mutations in Polish patients with dilated cardiomyopathy: prevalence, clinical characteristics, and in vitro studies.

Saj M, Bilinska ZT, Tarnowska A, Sioma A, Bolongo P, Sobieszczanska-Malek M, Michalak E, Golen D, Mazurkiewicz L, Malek L, Walczak E, Fidzianska A, Grzybowski J, Przybylski A, Zielinski T, Korewicki J, Tesson F, Ploski R.

BMC Med Genet. 2013 May 23;14:55. doi: 10.1186/1471-2350-14-55.

14.

Nuclear size of myocardial cells in end-stage cardiomyopathies.

Yan SM, Finato N, Di Loreto C, Beltrami CA.

Anal Quant Cytol Histol. 1999 Apr;21(2):174-80.

PMID:
10560488
15.

The cardiac mechanical stretch sensor machinery involves a Z disc complex that is defective in a subset of human dilated cardiomyopathy.

Knöll R, Hoshijima M, Hoffman HM, Person V, Lorenzen-Schmidt I, Bang ML, Hayashi T, Shiga N, Yasukawa H, Schaper W, McKenna W, Yokoyama M, Schork NJ, Omens JH, McCulloch AD, Kimura A, Gregorio CC, Poller W, Schaper J, Schultheiss HP, Chien KR.

Cell. 2002 Dec 27;111(7):943-55.

16.

Distinct functions of junD in cardiac hypertrophy and heart failure.

Ricci R, Eriksson U, Oudit GY, Eferl R, Akhmedov A, Sumara I, Sumara G, Kassiri Z, David JP, Bakiri L, Sasse B, Idarraga MH, Rath M, Kurz D, Theussl HC, Perriard JC, Backx P, Penninger JM, Wagner EF.

Genes Dev. 2005 Jan 15;19(2):208-13.

17.

MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure.

Arber S, Hunter JJ, Ross J Jr, Hongo M, Sansig G, Borg J, Perriard JC, Chien KR, Caroni P.

Cell. 1997 Feb 7;88(3):393-403.

18.

[Cardiomyocyte cytoskeleton in dilated cardiomyopathy and ischemic heart disease].

Beletskaia LV, Zhbanova LB, Zaĭdenov VA, Kurenkova LG, Riaboshtanova EI.

Arkh Patol. 1996 Mar-Apr;58(2):45-9. Russian.

PMID:
8712941
19.

Adenine nucleotide translocase 1 deficiency results in dilated cardiomyopathy with defects in myocardial mechanics, histopathological alterations, and activation of apoptosis.

Narula N, Zaragoza MV, Sengupta PP, Li P, Haider N, Verjans J, Waymire K, Vannan M, Wallace DC.

JACC Cardiovasc Imaging. 2011 Jan;4(1):1-10. doi: 10.1016/j.jcmg.2010.06.018.

20.

Knock-in mouse model of dilated cardiomyopathy caused by troponin mutation.

Du CK, Morimoto S, Nishii K, Minakami R, Ohta M, Tadano N, Lu QW, Wang YY, Zhan DY, Mochizuki M, Kita S, Miwa Y, Takahashi-Yanaga F, Iwamoto T, Ohtsuki I, Sasaguri T.

Circ Res. 2007 Jul 20;101(2):185-94. Epub 2007 Jun 7.

Supplemental Content

Support Center